The 2035 Fund is a bold new initiative to power the next generation of life sciences innovation in Massachusetts. Designed to accelerate cutting-edge research through partnerships, foster translation from lab to impact, and close critical infrastructure gaps, this fund will invest in the people, places, and technologies shaping the future of health and science.
The 2035 Fund is inclusive of several programmatic initiatives:
- Accelerating Research through Collaboration (ARC) Awards: Supports work that bridges basic science and real-world application, moving discoveries toward clinical, commercial, or societal impact.
- Research Infrastructure and Equipment: Grants to support the life sciences ecosystem through the purchase of cutting-edge research equipment available to researchers across the Commonwealth
- Biobank: Breaking barriers by establishing a disease-specific (Year 1: colorectal cancer and Alzheimer’s disease), accessible biobank driven by ecosystem feedback and need.
- Frontiers Fund: Supporting high-risk translational research in specific areas with urgent healthcare challenges historically overlooked in value-based investing.
- Women’s Health Initiative: Designed to close critical gaps in scientific understanding and clinical care for two of the most pressing and under-researched conditions affecting women: Pregnancy-Induced Hypertension and Perimenopause/Menopause
The application period will run from Aug. 5 to Nov. 21, 2025. Apply today.
Register for an upcoming virtual info session to learn more about the 2035 Fund and the MLSC’s current funding opportunities.
